Sentences with phrase «provide study patients»
• Provide study patients a caring and open communications while obtaining blood samples and process specimens following study protocol and laboratory instructions and procedures.
http://www.resumemycareer.com/ Not exact matches
We have now completed several health studies in partnership with the Geisinger Health System, which provides primary care to over 450,000 patients in Pennsylvania, including many residing in fracking areas.
After that, Watson will take assist by providing both physician and patient with a report that includes the most relevant drug trial and academic studies for their specific conditions.
The study offers more validation for the use of remote patient monitoring (RPM) wearables and devices to provide clinicians with fuller, more accurate patient data.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
A strength is that the study was performed in a large family practice teaching center, providing access to a wide spectrum of patients of various socioeconomic strata at one site.
This study provides detailed anaesthetic and peripartum management of women with congenital heart disease, a patient population in whom evidence - based practice and data are largely lacking.
For grade 3 (lowest quality), either breastfeeding information was not provided by the mother or a close relative of the patient, diagnosis was not confirmed by a physician, or control subjects were recruited to the study by the patients.
Thus, studies in which information about breastfeeding was not provided by the mother of the patient or an older close relative were assigned to the lowest quality group.
Patients and staff providing feedback to the study which led to the report complained that they «closed ranks» and that an official at a hospital's patient advice and liaison service department «barely looked at me and dismissed me with a leaflet».
With expertise in minimally invasive oncoplastic breast surgery, Dr. Wilson has also studied complementary medicine and provides her patients with a holistic, integrative approach to breast care.
Findings from a study into Crohn's disease, led by William G. Kerr, Ph.D., of SUNY Upstate Medical University, and his collaborators at the Erasmus Medical Center in the Netherlands, provide the first evidence that patients with debilitating inflammatory bowel disease lack sufficient quantities of a protein that comes from the SHIP1 gene.
The study provides evidence that patients of various ethnicities and religious backgrounds will be seeking information from their physicians on the issue, many of them at what may be the most vulnerable time in their lives, she said.
New research finds flaws in a 2009 study that had provided hope and one scientist says CFS patients should stop taking antiretroviral drugs based on those findings
The current study attempts to provide a more accurate picture of what is taking place at the genetic level when an AML patient has a relapse or metastasis of the disease.
«BOSON is a ground - breaking new study that provides information about how we can ensure the best outcomes for both GT - 2 and GT - 3 hepatitis C - infected patients.
The authors write that their study «provides reassurance that the individual risk of long - term opioid use in opioid - naive surgical patients is low.
While further study of larger patient groups with longer follow - up times is needed for this cohort of prostate cancer patients, this study is pivotal in providing evidence for change in practice.»
The results were from a study that was relatively small — only 208 patients — but provided a head - to - head comparison of niacin and ezetimibe, known by the brand name Zetia.
«In our study, 18F - fluoride PET / MR provided more diagnostic information at a higher diagnostic certainty compared to 18F - fluoride PET / CT in patients with foot pain of unclear cause,» states Isabel Rauscher, corresponding author of the study.
These data also provide support for intervention studies to examine the effects of the DASH diet on blood uric acid level among gout patients as well as for the risk of gout flares, they add.
«Moving forward, we'll need to conduct additional studies of many more patients to show that getting functional scans in the first hours or days after a stroke could provide valuable information for predicting outcome and tracking recovery.»
«Data from this study serves as rationale to now include dogs with spontaneous cancers in the advancement and optimization of PMed for human patients,» according to the study, Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials.
«By studying the issue of variation in practice patterns, the Mohs College hopes to improve the quality and value of care we provide our patients.»
If future similar studies can further expand and eventually provide a brain - based predictive best - therapy option for individual patients, it would dramatically decrease unnecessary exposure of patients to ineffective therapies and decrease the duration and magnitude of pain suffering and opioid use, Baliki and Apkarian said.
«We hope that our work will provide the basis for a larger study of patient samples that may ultimately identify biomarkers that can be used as surrogate markers to determine the benefit of therapeutic interventions in diagnosed but asymptomatic HD patients to prevent or delay disease onset.»
«Conducting formal readability testing, as suggested by the study authors, along with use of patient reviewers from a variety of educational and cultural backgrounds may provide important feedback to enhance the value of materials across a larger spectrum of health literacy levels.»
The goal, said Roman Gulati, the study's lead author, is to provide patients and clinicians with a tool that can help them better determine personalized treatment options.
«The abstracts we presented at WCLC are prime examples of how our growing body of research and studies at CTCA at Western are advancing medicine and hold the potential to provide patients with better cancer treatments,» Dr. Weiss said.
In this way, Warner said, the study advances the goal of personalized medicine, to diagnose conditions earlier and provide the most effective treatment based on patients» genetic and phenotypic characteristics.
The journal provides cutting - edge research including results from animal models that are likely to apply to patients, studies in human tissue that provide new information about therapies or disease, and innovative reports of drug discovery and development.
In addition to helping understand disease by providing more powerful study models, «what this technology would allow you to do is reprogram a skin cell, for example, from a Parkinson's patient... into a pluripotent cell and then in a petri dish redirect that cell into... a neuron» to treat that patient.
Elaine Mardis: In 2013 there were numerous studies [that provide] growing evidence that linking a patient's tumor genotype to a drug or drugs can achieve at least temporary remission.
The REACT (Randomized Evaluation of an Algorithm for Crohn's Treatment) study, led by Robarts Clinical Trials at Western University (London, Canada) provides valuable new insights for community gastroenterologists which should benefit patients.
A study of survival rates in trauma patients following health insurance reform in Massachusetts found a passing increase in adjusted mortality rates, an unexpected finding suggesting that simply providing insurance incentives and subsidies may not improve survival for trauma patients, according to a report published online by JAMA Surgery.
A technique using anesthesia - containing nanoparticles — drawn to the targeted area of the body by magnets — could one day provide a useful alternative to nerve block for local anesthesia in patients, suggests an experimental study in the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
The study, published in the September issue of Annals of Surgery online, shows that providing pricing information upfront can influence patient choice of surgical procedures and potentially lead to cost savings in health care, a sector of the economy that accounts for more than 17 percent of the U.S. Gross Domestic Product, says Eric R. Scaife, M.D., senior author, associate professor of surgery and chief of pediatric surgery at the University of Utah (U of U) School of Medicine.
The study was an investigation of 578 consecutive patients with heart attack due to a coronary artery blockage, who provided information on recent and usual occurrence of symptoms of respiratory infection.
This study «provides the first fairly targeted therapeutic opportunity for these patients,» says Susan Shurin, a hematologist and acting director of the Division of Blood Diseases and Resources at the National Heart, Lung and Blood Institute (NHLBI) in Bethesda, Md., noting that it paves the way for new treatments.
According to Dr. Cripe, the study suggests that some patients could respond to therapy even if their tumors aren't very infectable by the virus, provided their immune systems were stimulated by the viral therapy to attack the tumor cells.
The findings of this study may be useful for planning future support programs for cancer patients, and can provide additional information to guide programs for people with specific cancer types.
«The novelty of this study is that it provides potential neuroimaging - based tools that can be used with new patients to inform about the degree of certain neural pathology underlying their pain symptoms,» said Marina López - Solà, a post-doctoral researcher in CU Boulder's Cognitive and Affective Control Laboratory and lead author of the new study.
The study notes that there are several reasons patients did not receive additional physician follow - up including: patients believing they didn't need additional care and the lack of a coordinated referral system from the emergency department to physicians who can provide follow - up care.
In devising their experiment, the researchers took advantage of ambulance company practices that essentially provided a randomized group of patients to study, making it possible to compare outcomes at different hospitals.
This study provides the basis for a biomarker to determine which patients might be best to target with new treatments.»
Women considering abortions are getting medically inaccurate information nearly a third of the time in states that require doctors to provide informed consent materials to their patients, according to a Rutgers study.
Among patients with acute, low back pain presenting to an emergency department, neither the nonsteroidal anti-inflammatory drug (NSAID) naproxen combined with oxycodone / acetaminophen or the muscle relaxant cyclobenzaprine provided better pain relief or improvement in functional outcomes than naproxen combined with placebo, according to a study in the October 20 issue of JAMA.
The study, published in Alimentary Pharmacology & Therapeutics, provides evidence that using the non-invasive technology as a first - line test can rule out the need for further liver tests, and could stop patients having unnecessary biopsies.
This study speaks to the need to provide such patient - centered and culturally sensitive medical care.»
«This is the first study to show that a systemic therapy provides significant clinical benefit in a randomized fashion to advanced uveal melanoma patients, who have very limited treatment options,» said Richard D. Carvajal, MD, a medical oncologist at Memorial Sloan - Kettering and lead author on the study.